Floatz logo

Sanchitongshu

Ischemic Attack, Transient

Xinhua Hospital, Shanghai Jiao Tong University School of MedicineN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

21 Active assets in the Ischemic Attack, Transient cohort.

Asset / SponsorPhaseRating
Plavix
Sichuan Provincial People's Hospital
Phase 4BBB
Acetylsalicylic Acid
Sichuan Provincial People's Hospital
Phase 4BBB
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Stanford University
Phase 4BBB
Ticagrelor
Mazandaran University of Medical Sciences
Phase 3BBB
Apixaban
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Phase 4BBB

View all 45 →

Same molecule, other indications

Sanchitongshu is also rated in:

stroke disorderDormant
D
Indicative ·
30 / 100
View asset →
Antiplatelet EffectDormant
D
Indicative ·
30 / 100
View asset →
ischemic strokeDormant
D
Indicative ·
28 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →